Asthma drug may stunt growth permanently – NBCNews.com (blog)


Washington University in St. Louis News

Asthma drug may stunt growth permanently
NBCNews.com (blog)
An inhaled drug commonly used to treat children with asthma cuts about half an inch off their height permanently, researchers reported on Monday. But the good news is that the stunting effect doesn't get worse over time, the researchers report in the
Child's Use of Certain Asthma Drugs Could Shorten Adult HeightU.S. News & World Report
Children taking steroids for asthma are slightly shorter than peersPhys.Org

all 10 news articles »

View full post on asthma – Google News

Synairgen in Drug Partnership Talks After Study Results – Businessweek

Synairgen in Drug Partnership Talks After Study Results
Businessweek
Synairgen Plc (SNG) is in talks with potential partners following the results of a study of an experimental medicine targeting infections that trigger asthma attacks, Chief Executive Officer Richard Marsden said. Synairgen is speaking with larger
New drug 'stops common cold asthma deaths'Hayling Islander

all 3 news articles »

View full post on asthma – Google News

Pfizer, Boehringer’s Drug Helped to Delay Asthma Attacks – Businessweek

Pfizer, Boehringer's Drug Helped to Delay Asthma Attacks
Businessweek
A lung drug from Boehringer Ingelheim GmbH and Pfizer Inc. (PFE) helped delay severe episodes in asthma patients, researchers said today in two studies that may result in broader use of the medicine. Spiriva, known chemically as tiotropium, cut the
First Phase III Data for Tiotropium in Symptomatic Asthma Patients Treated Sacramento Bee
Phase III results: tiotropiumA Respimat® significantly reduces exacerbations Financial Post

all 13 news articles »

View full post on asthma – Google News

Bradford physician reveals drug breakthrough for asthma patients – Bradford Telegraph and Argus

Bradford physician reveals drug breakthrough for asthma patients
Bradford Telegraph and Argus
Startling results of a research trial in Bradford into the effectiveness of a drug to treat severe allergic asthma have been presented to the European Respiratory Society congress in Vienna. Bradford Teaching Hospitals NHS Foundation Trust was one of

View full post on asthma – Google News

GSK severe asthma drug progresses to Phase III – InPharm


InPharm

GSK severe asthma drug progresses to Phase III
InPharm
The Phase IIb DREAM study was testing mepolizumab in patients with severe eosinophilic asthma, a condition where organs are damaged by the over-production of white blood cells. The year-long study, which involved 621 patients, found the number of
GSK asthma drug cuts symptoms 52%; ready for PhIIIPharma Times
GSK drug halves attacks in hard-to-treat asthmaBusiness Recorder (blog)
Drug 'could cut asthma A&E visits'World First Travel Insurance
The Inquisitr –Zenopa
all 6 news articles »

View full post on asthma – Google News

GSK asthma drug cuts symptoms 52%; ready for PhIII – Pharma Times


World First Travel Insurance

GSK asthma drug cuts symptoms 52%; ready for PhIII
Pharma Times
GlaxoSmithKline's mepolizumab is now ready for late-stage testing after turning in a strong performance in Phase II trials assessing the experimental drug in a rare and hard-to-treat form of asthma. The Phase IIb trial was designed to investigate
GSK drug halves attacks in hard-to-treat asthmaBusiness Recorder (blog)
Drug 'could cut asthma A&E visits'World First Travel Insurance
Experimental Asthma Drug Halves AttacksThe Inquisitr

all 4 news articles »

View full post on asthma – Google News

Experimental Asthma Drug Halves Attacks – The Inquisitr


Telegraph.co.uk

Experimental Asthma Drug Halves Attacks
The Inquisitr
The Telegraph reports the medicine is called mepolizumab and treats a rare form of the condition in which white blood cells called eosinophils cause lung airways to become inflamed. The new asthma drug is injected, and reduces the number of eosinophils
Glaxo's Experimental Drug Halves Asthma Attacks in StudyBusinessweek
Experimental Drug May Cut Severe Asthma Attacks: StudyPhiladelphia Inquirer
GSK drug halves attacks in hard-to-treat asthmaChicago Tribune
Fox News
all 36 news articles »

View full post on asthma – Google News